2022
DOI: 10.3389/fcvm.2022.862001
|View full text |Cite
|
Sign up to set email alerts
|

Reduction of Cardiac Autonomic Modulation and Increased Sympathetic Activity by Heart Rate Variability in Patients With Long COVID

Abstract: Although several clinical manifestations of persistent long coronavirus disease (COVID-19) have been documented, their effects on the cardiovascular and autonomic nervous system over the long term remain unclear. Thus, we examined the presence of alterations in cardiac autonomic functioning in individuals with long-term manifestations. The study was conducted from October 2020 to May 2021, and an autonomic assessment was performed to collect heart rate data for the heart rate variability (HRV) analysis. The st… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
23
1

Year Published

2022
2022
2023
2023

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 45 publications
(38 citation statements)
references
References 35 publications
3
23
1
Order By: Relevance
“… 45 Furthermore, a study by Marques et al revealed a reduction in HRV with increased sympathetic modulation, and a decrease in parasympathetic modulation in long COVID. 46 Cardiac autonomic dysfunction has also been reported during the early stage of COVID-19 diseases. Milovanovic et al showed sympathetic dysfunction with orthostatic hypotension in about 46.3%, and abnormal handgrip tests in about 94.4% of post-COVID patients.…”
Section: Discussionmentioning
confidence: 98%
“… 45 Furthermore, a study by Marques et al revealed a reduction in HRV with increased sympathetic modulation, and a decrease in parasympathetic modulation in long COVID. 46 Cardiac autonomic dysfunction has also been reported during the early stage of COVID-19 diseases. Milovanovic et al showed sympathetic dysfunction with orthostatic hypotension in about 46.3%, and abnormal handgrip tests in about 94.4% of post-COVID patients.…”
Section: Discussionmentioning
confidence: 98%
“…Using longer-duration wearable sensor data, Radin et al showed that subjects with COVID-19 exhibited transient bradycardia followed by a prolonged tachycardia, which did not return to baseline until 79 days on average after the symptom onset [ 101 ]. It has been reported that patients with long COVID showed increased sympathetic activity and parasympathetic reduction [ 102 ]. Recently, Mills et al demonstrated that bromodomain and extra-terminal protein (BET) family inhibitors prevented diastolic dysfunction and death in a mouse cytokine-storm model via reduction of SARS-CoV-2 infection of cardiomyocytes by decreasing ACE2 expression [ 103 ].…”
Section: Mechanisms For Long Covid and Cardiovascular Damagementioning
confidence: 99%
“…In order to provide evidence in favor of the dysautonomia hypothesis, we investigated heart rate variability (HRV) in both the time and frequency domains by performing a non-invasive study of sympathetic and parasympathetic activity in long COVID-19 patients. HRV [31][32][33][34][35] is a legitimate dysautonomia diagnosis. It is possible that HRV may be a useful tool for examining the neuroimmune systems and inflammatory processes of long COVID-19 patients.…”
Section: Discussionmentioning
confidence: 99%